Insulin glargine, recombinant Subcutaneous and Metozolv ODT
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Metozolv ODT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: metoclopramide
Brand name: Metozolv ODT, Reglan
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Metreleptin
- Insulin glargine, recombinant Subcutaneous-Metreleptin Subcutaneous
- Insulin glargine, recombinant Subcutaneous-MetroCream
- Insulin glargine, recombinant Subcutaneous-Metrocream Topical
- Insulin glargine, recombinant Subcutaneous-MetroGel
- Insulin glargine, recombinant Subcutaneous-MetroGel (Metronidazole Cream, Gel, and Lotion)
- Metozolv ODT-Insulin glulisine
- Metozolv ODT-Insulin Glulisine (Cartridges and Pens)
- Metozolv ODT-Insulin Glulisine (Vials)
- Metozolv ODT-Insulin glulisine Subcutaneous
- Metozolv ODT-Insulin human inhaled Inhalation
- Metozolv ODT-Insulin human regular Injection